Dr. Croop is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
705 Riley Hospital Dr
# Roc
Indianapolis, IN 46202Phone+1 317-944-5611Fax+1 317-944-3107- Is this information wrong?
Education & Training
- Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 1983 - 1986
- Children's Hospital of PhiladelphiaResidency, Pediatrics, 1980 - 1983
- Perelman School of Medicine at the University of PennsylvaniaClass of 1980
Certifications & Licensure
- IN State Medical License 1997 - 2025
- MA State Medical License 1983 - 2011
- PA State Medical License 1982 - 1988
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2009-2014
- America's Top Doctors for Cancer Castle Connolly, 2008-2013
- Indianapolis Monthly Castle Connolly, 2011, 2013
- Join now to see all
Clinical Trials
- Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors Start of enrollment: 2000 Feb 01
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
- Combination Chemotherapy With or Without Radiation Therapy in Treating Young Patients With Newly Diagnosed Stage III or Stage IV Wilms' Tumor Start of enrollment: 2007 Feb 26
- Join now to see all
Publications & Presentations
PubMed
- 164 citationsIsolation and characterization of DNA sequences amplified in multidrug-resistant hamster cellsPhilippe Gros, James M. Croop, Igor B. Roninson, Alexander Varshavsky, David E. Housman
Proceedings of the National Academy of Sciences of the United States of America. 1986-01-01 - 145 citationsImatinib mesylate for plexiform neurofibromas in patients with neurofibromatosis type 1: a phase 2 trialKent A. Robertson, Grzegorz Nalepa, Feng Chun Yang, Daniel C. Bowers, Chang Y. Ho
The Lancet. Oncology. 2012-12-01 - 93 citationsPhase I and Pharmacokinetic Study of Gefitinib in Children With Refractory Solid Tumors: A Children’s Oncology Group StudyNajat C. Daw, Wayne L. Furman, Clinton F. Stewart, Lisa C. Iacono, Mark Krailo
Journal of Clinical Oncology. 2005-09-01
Press Mentions
- Riley Doctor Using Magic as MedicineFebruary 7th, 2019
Grant Support
- Transduction Of Cd34+Periph.Bld Cells W/Gp91 In X-Linked Chr Granulomatous DIS.National Center For Research Resources2004
- Procarbazine, CCNU, Vincristine For Poor Prognosis Pediatric/Adult Brain TumorNational Center For Research Resources2004
- Clinical Research FacilityNational Cancer Institute2000–2002
- Core--Gene Therapy Working Group/BiostatisticsNational Institute Of Diabetes And Digestive And Kidney Diseases1999–2002
- Immunologic Analysis--Multidrug Resistant Gene FamilyNational Cancer Institute1988–1992
- Multidrug Resistance Genes--Analysis And ApplicationsNational Cancer Institute1987–1991
Professional Memberships
- American Society of Pediatric Hematology OncologyMember
- The Children's Oncology GroupMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: